# Eugia Pharma Specialities Limited - Inspection Records Source: https://www.globalkeysolutions.net/companies/eugia-pharma-specialities-limited/9733456f-3189-4fe6-a4f9-327f0ce92559 > Inspection records and compliance data for Eugia Pharma Specialities Limited in Pashamylaram, None. Access full analysis and detailed observations. --- ## Details - Name: Eugia Pharma Specialities Limited - FEI Number: 3008461619 - City: Pashamylaram - State: None - Country Name: India - Address Line 1: 34 - 48 Plot No 4, Unit Iii; Ida - Zip Code: None - Facility Type: Manufacturer of sterile drug products - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK ## Related Documents - [EMA GMP - Eugia Pharma Specialities Limited - FT020/SA/002/2023/NCR - 2026-03-27](https://www.globalkeysolutions.net/records/ema/eugia-pharma-specialities-limited/d2679069-1b88-41a5-8bde-985c5b74683e) — source: EMA, date: March 27, 2026 - [483 - Eugia Pharma Specialities Limited - 2026-02-06](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/4de3a2c8-d7e4-4c76-b46e-713f1d206518) — source: FDA, date: February 6, 2026 - [FDA Inspection 1301166 - Eugia Pharma Specialities Limited - 2026-02-06](https://www.globalkeysolutions.net/records/fda_inspections/eugia-pharma-specialities-limited/dad2a99c-72eb-441c-b664-de937e749c6e) — source: FDA, date: February 6, 2026 - [483 - Eugia Pharma Specialities Limited - 2026-01-27](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/e061c5af-789c-4a1d-bc2f-3e5a527a7a7a) — source: FDA, date: January 27, 2026 - [483 - Eugia Pharma Specialities Limited - 2024-02-02](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/57b7752a-e2b3-4408-b72d-45de97bb3551) — source: FDA, date: February 2, 2024 - [FDA Inspection 1228546 - Eugia Pharma Specialities Limited - 2024-02-02](https://www.globalkeysolutions.net/records/fda_inspections/eugia-pharma-specialities-limited/85cbcceb-815e-487e-9426-4c272f86d63a) — classification: Official Action Indicated (OAI), source: FDA, date: February 2, 2024 - [483 - Eugia Pharma Specialities Limited - 2019-11-13](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/414d62e8-c6c9-4214-ba53-cc56bdc079d3) — source: FDA, date: November 13, 2019 - [483 - Eugia Pharma Specialities Limited - 2018-12-14](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/ba5f5ab2-9af9-4614-9470-b9b649b27bed) — source: FDA, date: December 14, 2018 - [483 - Eugia Pharma Specialities Limited - 2018-12-14](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/05698986-cd1a-4aaa-9f96-85f99153f0a4) — source: FDA, date: December 14, 2018 - [FDA Inspection 1074573 - Eugia Pharma Specialities Limited - 2018-12-14](https://www.globalkeysolutions.net/records/fda_inspections/eugia-pharma-specialities-limited/8a7d51e6-f2bc-408c-931c-6c2f2a26379d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 14, 2018 - [483 - Eugia Pharma Specialities Limited - 2018-02-20](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/a79eaef1-d0d8-477c-9fe3-124b321d92aa) — source: FDA, date: February 20, 2018 - [FDA Inspection 1041554 - Eugia Pharma Specialities Limited - 2018-02-20](https://www.globalkeysolutions.net/records/fda_inspections/eugia-pharma-specialities-limited/41a9fa50-d8f9-4cc4-a232-a9335fafebf0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 20, 2018 - [483 - Eugia Pharma Specialities Limited - 2017-04-28](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/2e2978c9-6a02-4cce-a0c4-1163d3a8b660) — source: FDA, date: April 28, 2017 - [483 - Eugia Pharma Specialities Limited - 2016-09-16](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/ebfbac56-710d-4628-9e59-2850049140f8) — source: FDA, date: September 16, 2016 - [FDA Inspection 989530 - Eugia Pharma Specialities Limited - 2016-09-16](https://www.globalkeysolutions.net/records/fda_inspections/eugia-pharma-specialities-limited/f95cbf45-4a39-478f-a3ce-72bade782b34) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 16, 2016 - [FDA Inspection 901293 - Eugia Pharma Specialities Limited - 2014-09-26](https://www.globalkeysolutions.net/records/fda_inspections/eugia-pharma-specialities-limited/a0dbd24a-55cc-4b3c-ae1a-d0cde6fe9959) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 26, 2014 - [FDA Inspection 798035 - Eugia Pharma Specialities Limited - 2012-09-12](https://www.globalkeysolutions.net/records/fda_inspections/eugia-pharma-specialities-limited/40890a61-b399-4567-b3a0-d1a43dfe09d5) — classification: No Action Indicated (NAI), source: FDA, date: September 12, 2012 ## Related Companies - [Biocon Biologics Limited](https://www.globalkeysolutions.net/companies/biocon-biologics-limited/7eb84509-8dc4-4765-9a0e-d2f65781328d) - [GlaxoSmithKline Biologicals](https://www.globalkeysolutions.net/companies/glaxosmithkline-biologicals/98ade6fb-8ae1-48af-a7cf-71b26cd2e808) - [Teyro Labs Private Limited](https://www.globalkeysolutions.net/companies/teyro-labs-private-limited/8744f9fc-f440-4610-ac34-05b15c46173b) - [Dr. Reddy’s Laboratories Limited](https://www.globalkeysolutions.net/companies/dr-reddys-laboratories-limited/19f1fec5-d1fb-47f3-92bb-7e3e0f0db5d6) - [RK Pharma Inc.](https://www.globalkeysolutions.net/companies/rk-pharma-inc/04d6c855-6dac-45ed-8597-0541bddd3bce) - [Shilpa Medicare Limited](https://www.globalkeysolutions.net/companies/shilpa-medicare-limited/9184777f-89bb-4a33-bcb2-4cc2aa4eb655) - [Dr Reddy's Laboratories Limited](https://www.globalkeysolutions.net/companies/dr-reddys-laboratories-limited/97f3d461-62f0-4198-9e9d-7f7c7d43af86) - [Mankind Pharma Limited](https://www.globalkeysolutions.net/companies/mankind-pharma-limited/448ddf49-4ff4-4a2b-8444-e8cc23677777) - [Evonik Corporation](https://www.globalkeysolutions.net/companies/evonik-corporation/f88f3afa-3508-4fc2-8d70-8558ece37d59) - [Pharmathen International S.A.](https://www.globalkeysolutions.net/companies/pharmathen-international-sa/4486b3e5-4ce8-40ff-80da-e4364db37198) ## Related Officers - [Jose A. Cruz Gonzalez](https://www.globalkeysolutions.net/people/jose-a-cruz-gonzalez/a005cff1-0a90-4396-82c4-de4b0a579374) - [Scott T. Ballard](https://www.globalkeysolutions.net/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da) - [Saleem A. Akhtar](https://www.globalkeysolutions.net/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf) - [Mark L. Baum](https://www.globalkeysolutions.net/people/mark-l-baum/03c8bd98-912b-43f9-9e41-6ffb00bc3cfe) - [Anne P. Reid](https://www.globalkeysolutions.net/people/anne-p-reid/123cf007-29c4-4da6-83c3-228c8af415dc)